Accession Number: | 0000905148-20-000752 |
Date: | 2020-06-30 |
Issuer: | APREA THERAPEUTICS, INC. (APRE) |
Original Submission Date: |
HENNEMAN JOHN B III
535 BOYLSTON STREET
BOSTON, MA 02116
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 38.78 | 2020-06-30 | deemed execution date | A | 5,600 (a) | 2030-06-30 | common stock 5,600 | $38.78 | 5,600 | direct |
ID | footnote |
---|---|
f1 | the option vests in full on june 30, 2021 subject to the reporting person's continued service on the issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions. |